Novocure seeks approval after pancreatic cancer wearable scores at Phase III
Novocure is seeking regulatory approval in the US, EU, Japan and other key markets after the Phase III PANOVA-3 pancreatic …
Novocure is seeking regulatory approval in the US, EU, Japan and other key markets after the Phase III PANOVA-3 pancreatic …
Baxter has issued a correction for its AK 98 haemodialysis machines, with the US Food and Drug Administration (FDA) classifying …
The US Food and Drug Administration (FDA) has granted breakthrough device designation to deepull’s UllCORE bloodstream infection (BSI) test. The test, …
US-based Silo Pharma has partnered with North Carolina-based Kymanox to jointly design and develop a subcutaneous insertion device for SP-26, …
United Lincolnshire Hospitals NHS Trust in the UK has announced the opening of the Skegness Community Diagnostic Centre (CDC) to …
GE HealthCare has launched Sonic DL for 3D, the latest addition to its imaging portfolio that aims to expedite magnetic …
Recent research highlights groundbreaking progress in the development of adaptive cardiac monitoring and therapeutic devices, showcasing the transformative potential of …
A pivotal investigator-led clinical trial for a new ‘pill-on-a-thread’ innovation for oesophageal cancer screening has welcomed its first patients, Cambridge …
Medtronic has reported new clinical data from the study of its Evolut transcatheter aortic valve replacement (TAVR) system, which is …
UK-based Albus Health (formerly BreathOx) has shared data revealing that its Albus Home AI-powered monitoring device can detect warning signs …
The Egypt Healthcare Authority (EHA), Roche Diagnostics and Roche Pharmaceuticals have signed a memorandum of understanding (MOU) to advance digital …
Israel-based PixCell Medical has received a CE mark for HemoScreen, a complete blood count analyser (CBC), under the EU’s In …
Swedish magnetic resonance imaging (MRI) software developer SyntheticMR is looking to expand its offerings to include cloud-based and AI-driven platforms …
QIAGEN has announced a new site in Esplugues de Llobregat, Barcelona, Spain, to shift its QIAstat-Dx system operations. This move is …
Leading lead generation providers and technology solutions for the medical device industry: Introduction In the fast-paced and ever-evolving medical device industry, …